Related Experiment Video
Updated: Jun 9, 2025
11:17
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
13.7K
Multifaceted Heparin: Diverse Applications beyond Anticoagulant Therapy
Razia Sultana1,2, Masamichi Kamihira1
1Department of Chemical Engineering, Faculty of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan.
Pharmaceuticals (Basel, Switzerland)
|October 26, 2024
Summary
Heparin, a vital anticoagulant, shows promise beyond blood thinning, with emerging anti-inflammatory, antiviral, and anti-tumor roles. Nanotechnology enhances its therapeutic potential for future medical applications.
Area of Science:
- Biochemistry and Pharmacology
- Biomaterials and Nanotechnology
Background:
- Heparin, a naturally occurring polysaccharide, has been a cornerstone anticoagulant therapy for nearly a century.
- Its therapeutic applications extend beyond anticoagulation, with documented anti-inflammatory, antiviral, and anti-tumorigenic activities.
Purpose of the Study:
- To provide a comprehensive profile of heparin, detailing its current therapeutic utilities.
- To explore emerging applications of heparin, particularly in bioengineering and nanotechnology.
- To discuss the challenges and opportunities in advancing heparin-based therapies.
Main Methods:
- Review of existing literature on heparin's biological properties and therapeutic uses.
- Analysis of recent advancements in nanotechnology and their impact on heparin's biofunctionalities.
- Exploration of future research directions in heparin bioengineering.
Main Results:
- Heparin exhibits diverse biological activities, including anticoagulation, anti-inflammatory, antiviral, and anti-tumorigenic effects.
- Nanotechnology integration significantly enhances heparin's therapeutic efficacy and delivery.
- Potential for expanded use in treating thrombotic disorders, infectious diseases (e.g., COVID-19), and cancer.
Conclusions:
- Heparin possesses multifaceted therapeutic potential beyond its established anticoagulant role.
- Advancements in nanotechnology offer novel strategies to harness and improve heparin's biofunctionalities.
- Further research and development are crucial to fully realize heparin's potential in improving patient outcomes.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
625
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
625
01:29Venous Thrombosis III: Interprofessional Care
2
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
2
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
478
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
478
01:30Venous Thrombosis IV: Nursing Management
2
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
2
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...